Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (SHA:688505)

China flag China · Delayed Price · Currency is CNY
7.14
+0.38 (5.62%)
Jun 18, 2026, 3:00 PM CST
Market Cap5.73B -13.2%
Revenue (ttm)654.94M -11.7%
Net Income-152.39M
EPS-0.15
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividend0.03 (0.44%)
Ex-Dividend DateJul 18, 2025
Volume14,784,453
Open6.78
Previous Close6.76
Day's Range6.68 - 7.53
52-Week Range6.58 - 11.69
Beta0.09
Analystsn/a
Price Targetn/a
Earnings DateAug 12, 2026

About SHA:688505

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China. It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs. The company was founded in 1996 and is based in Shanghai, the People's Republic of China. [Read more]

Sector Healthcare
Founded 1996
Employees 876
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688505

Financial Performance

Financial Statements